Maternal Grandmothers in the Born in Guangzhou Cohort Study

NCT03633162 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-10-01

No results posted yet for this study

Summary

The MGBIG is a study exploring cross-generational effects in 5000 women and their children and grandchildren located in Guangzhou, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology and on explaining the cause of the disease from the perspective of "grandmother-mother-child" heredity. Data are collected regarding environmental exposures, lifestyle, and social support on grandmother from birth to old age. Biological samples including blood and tissue samples are collected.

Conditions

  • Hereditary Transmission
  • Immune Development
  • Childhood Obesity
  • Host and Microbiome
  • Neurodevelopment

Interventions

OTHER

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • University of Birmingham

    collaborator OTHER
  • Guangzhou Women and Children's Medical Center

    lead OTHER

Principal Investigators

  • Xiu Qiu, PhD · Guangzhou Women and Children's Medical Center, China

Eligibility

Min Age
36 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-21
Primary Completion
2025-12-31
Completion
2038-12-31

Countries

  • China

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03633162 on ClinicalTrials.gov